BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9333018)

  • 1. Activation of multiple growth regulatory genes following inducible expression of IRF-1 or IRF/RelA fusion proteins.
    Nguyen H; Lin R; Hiscott J
    Oncogene; 1997 Sep; 15(12):1425-35. PubMed ID: 9333018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of transcription factor interferon regulatory factor-1 by interferon-gamma (IFN gamma) and tumor necrosis factor-alpha (TNF alpha) in FRTL-5 cells.
    Mori K; Stone S; Khaodhiar L; Braverman LE; DeVito WJ
    J Cell Biochem; 1999 Aug; 74(2):211-9. PubMed ID: 10404391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of IFN regulatory factor family proteins in lymphocytes. Induction of Stat-1 and IFN consensus sequence binding protein expression by T cell activation.
    Nelson N; Kanno Y; Hong C; Contursi C; Fujita T; Fowlkes BJ; O'Connell E; Hu-Li J; Paul WE; Jankovic D; Sher AF; Coligan JE; Thornton A; Appella E; Yang Y; Ozato K
    J Immunol; 1996 May; 156(10):3711-20. PubMed ID: 8621906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dominant negative mutant of an IFN regulatory factor family protein inhibits both type I and type II IFN-stimulated gene expression and antiproliferative activity of IFNs.
    Thornton AM; Ogryzko VV; Dent A; Sharf R; Levi BZ; Kanno Y; Staudt LM; Howard BH; Ozato K
    J Immunol; 1996 Dec; 157(11):5145-54. PubMed ID: 8943426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed tyrosine phosphorylation and nuclear expression of STAT1 following antigen receptor stimulation of B lymphocytes.
    Karras JG; Huo L; Wang Z; Frank DA; Zimmet JM; Rothstein TL
    J Immunol; 1996 Sep; 157(6):2299-309. PubMed ID: 8805627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of interferon regulatory factor 1 and S100C/A11 in growth inhibition by transforming growth factor beta 1 in human hepatocellular carcinoma cells.
    Miyazaki M; Sakaguchi M; Akiyama I; Sakaguchi Y; Nagamori S; Huh NH
    Cancer Res; 2004 Jun; 64(12):4155-61. PubMed ID: 15205326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 16-kDa prolactin down-regulates inducible nitric oxide synthase expression through inhibition of the signal transducer and activator of transcription 1/IFN regulatory factor-1 pathway.
    Lee SH; Nishino M; Mazumdar T; Garcia GE; Galfione M; Lee FL; Lee CL; Liang A; Kim J; Feng L; Eissa NT; Lin SH; Yu-Lee LY
    Cancer Res; 2005 Sep; 65(17):7984-92. PubMed ID: 16140971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour necrosis factor-alpha and interferon-gamma synergistically activate the RANTES promoter through nuclear factor kappaB and interferon regulatory factor 1 (IRF-1) transcription factors.
    Lee AH; Hong JH; Seo YS
    Biochem J; 2000 Aug; 350 Pt 1(Pt 1):131-8. PubMed ID: 10926836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IRF-1 reverts the transformed phenotype of oncogenically transformed cells in vitro and in vivo.
    Kröger A; Dallügge A; Kirchhoff S; Hauser H
    Oncogene; 2003 Feb; 22(7):1045-56. PubMed ID: 12592391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus core protein modulates the interferon-induced transacting factors of Jak/Stat signaling pathway but does not affect the activation of downstream IRF-1 or 561 gene.
    Basu A; Meyer K; Ray RB; Ray R
    Virology; 2001 Sep; 288(2):379-90. PubMed ID: 11601909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirement for STAT1 in LPS-induced gene expression in macrophages.
    Ohmori Y; Hamilton TA
    J Leukoc Biol; 2001 Apr; 69(4):598-604. PubMed ID: 11310846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent activation of p21WAF1 transcription by all-trans-acid in cervical squamous carcinoma cells.
    Arany I; Whitehead WE; Ember IA; Tyring SK
    Anticancer Res; 2003; 23(1A):495-7. PubMed ID: 12680256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the protein kinase PKR in modulated by IRF-1 and is reduced in 5q- associated leukemias.
    Beretta L; Gabbay M; Berger R; Hanash SM; Sonenberg N
    Oncogene; 1996 Apr; 12(7):1593-6. PubMed ID: 8622878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooperative activity between HER oncogenes and the tumor suppressor IRF-1 results in apoptosis.
    Kirchhoff S; Hauser H
    Oncogene; 1999 Jun; 18(25):3725-36. PubMed ID: 10391680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IRF-1 induced cell growth inhibition and interferon induction requires the activity of the protein kinase PKR.
    Kirchhoff S; Koromilas AE; Schaper F; Grashoff M; Sonenberg N; Hauser H
    Oncogene; 1995 Aug; 11(3):439-45. PubMed ID: 7543195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
    Chen X; Kandasamy K; Srivastava RK
    Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma regulation of the human mimecan promoter.
    Tasheva ES; Conrad GW
    Mol Vis; 2003 Jun; 9():277-87. PubMed ID: 12835654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription factor IRF-2 exerts its oncogenic phenotype through the DNA binding/transcription repression domain.
    Nguyen H; Mustafa A; Hiscott J; Lin R
    Oncogene; 1995 Aug; 11(3):537-44. PubMed ID: 7630638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles virus activates NF-kappa B and STAT transcription factors and production of IFN-alpha/beta and IL-6 in the human lung epithelial cell line A549.
    Helin E; Vainionpää R; Hyypiä T; Julkunen I; Matikainen S
    Virology; 2001 Nov; 290(1):1-10. PubMed ID: 11882993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.